Antibody-Drug Conjugates for Solid Tumors: Progress, Possibilities, and Implications for Care

  Рет қаралды 3,064

PeerView Oncology

PeerView Oncology

Күн бұрын

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.
For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CE/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/BUC865. CME/NCPD/CE/CPE/AAPA credit will be available until December 9, 2024.
Antibody-Drug Conjugates, the Ultimate Weapons Against Solid Tumors: Latest Progress, Future Possibilities, and Implications for Patient Care
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.
Disclosure Policy
All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Faculty/Planner Disclosures
Chair/Planner
Beth Sandy, MSN, CRNP, FAPO, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for AbbVie Inc. and Janssen Pharmaceuticals, Inc.
Speakers Bureau participant with Amgen Inc.; AstraZeneca; Jazz Pharmaceuticals, Inc.; Lilly; Merck & Co., Inc.; and Takeda Pharmaceutical Company Limited.
Faculty/Planner
Jamie Carroll, APRN, CNP, MSN, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Lilly; Novartis Pharmaceuticals Corporation; Pfizer; Sermonix Pharmaceuticals; and Talzenna.
Speakers Bureau participant with Horizon CME and OncLive.
Faculty/Planner
Elizabeth Prechtel Dunphy, DNP, RN, ANP-BC, AOCN, has a financial interest/relationship or affiliation in the form of:
Speakers Bureau participant with Incyte.
Planning Committee and Reviewer Disclosures
Planners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

Пікірлер
Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology Conference
27:03
Smart Steps for Effective Real-World Care in RCC
1:01:35
PeerView Oncology
Рет қаралды 157
99.9% IMPOSSIBLE
00:24
STORROR
Рет қаралды 31 МЛН
It works #beatbox #tiktok
00:34
BeatboxJCOP
Рет қаралды 41 МЛН
Сестра обхитрила!
00:17
Victoria Portfolio
Рет қаралды 958 М.
Part 11 - Evolution of Antibody Drug conjugates in cancer - Dr. Gail Phillips, USA
28:55
Manage Health Foundation MHF
Рет қаралды 7 М.
Bioconjugation CMC: Successfully Executing a Complex Process
21:14
BioProcess International
Рет қаралды 890
The Cancer Expert: "This Common Food Is Making Cancer Worse!"
1:37:34
The Diary Of A CEO
Рет қаралды 6 МЛН
Resect and Protect Against Melanoma Recurrence
29:04
PeerView Oncology
Рет қаралды 131
The World’s No.1 Sleep Expert: The 6 Sleep Hacks You NEED! Matthew Walker
2:05:41
Antibody Drug Conjugates for Cancer
56:32
Woo University
Рет қаралды 4,7 М.
Asking The Uncomfortable Questions About Vaccines | Dr. Paul Offit
1:33:34
Advancing Therapeutic Control in Desmoid Tumors
49:04
PeerView Oncology
Рет қаралды 154
Prof. Robert Lustig - 'Sugar, metabolic syndrome, and cancer'
57:42
Low Carb Down Under
Рет қаралды 1 МЛН
Antibody Drug Conjugates Present and Future Applications in Breast Cancer
25:46
99.9% IMPOSSIBLE
00:24
STORROR
Рет қаралды 31 МЛН